Foster Group
VIR icon

Foster Group’s Vir Biotechnology VIR Stock Holding History

Foster Group’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$115K Sell
10,243
-5
-0% -$50 ﹤0.01% 308
2026
Q2 		$104K Buy
10,248
+175
+2% +$1.66K ﹤0.01% 313
2026
Q1 		$90.3K Buy
+10,073
New +$80.3K ﹤0.01% 280

Other funds holding VIR

Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Atria Investments
Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FIA
FNY Investment Advisers New York $402M AUM 85.34% 1-Year Est. Return
Versant Capital Management
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
NL
NVWM LLC Yardley, Pennsylvania $533M AUM 27.53% 1-Year Est. Return
PWMG
Private Wealth Management Group Princeton, New Jersey $445M AUM 13.54% 1-Year Est. Return

Foster Group's VIR Position: Q3 2026 in Review

Foster Group reduced its Vir Biotechnology (VIR) stake by 0.05% in Q3 2026, selling an estimated $50 and leaving 10,243 shares worth $115K. The position accounts for ﹤0.01% of the portfolio, ranked #308.

Foster Group first reported a position in VIR in Q1 2026 and has held it in 3 quarters since. 21 funds tracked by Wall St. Rank hold VIR as of Q3 2026.

  • Foster Group held 10,243 shares of Vir Biotechnology worth $115K as of Q3 2026.
  • Foster Group sold 5 Vir Biotechnology shares in Q3 2026, an estimated $50.
  • Vir Biotechnology made up ﹤0.01% of Foster Group's portfolio in Q3 2026, its #308 holding.
  • Foster Group first reported a position in Vir Biotechnology in Q1 2026 and has held it in 3 quarters since.
  • 21 funds tracked by Wall St. Rank held Vir Biotechnology as of Q3 2026.

Based on Foster Group's 13F filing for Q3 2026, filed 13 Oct 2026.